Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP811801.RA1qMSpyuQJELTjXpZjD1iMo4cKMYR2sHIbv4yZFek9bU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP811801.RA1qMSpyuQJELTjXpZjD1iMo4cKMYR2sHIbv4yZFek9bU130_assertion type Assertion NP811801.RA1qMSpyuQJELTjXpZjD1iMo4cKMYR2sHIbv4yZFek9bU130_head.
- NP811801.RA1qMSpyuQJELTjXpZjD1iMo4cKMYR2sHIbv4yZFek9bU130_assertion description "[Combination treatment with 4-1BBL/anti-CD20 fusion protein and anti-CD3/anti-CD20 diabody led to significantly increased T-cell cytotoxicity to human B-lymphoma cells in vitro and drastically more potent tumor inhibitory activity in vivo in xenografted B-cell lymphoma in severe combined immunodeficiency disease mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP811801.RA1qMSpyuQJELTjXpZjD1iMo4cKMYR2sHIbv4yZFek9bU130_provenance.
- NP811801.RA1qMSpyuQJELTjXpZjD1iMo4cKMYR2sHIbv4yZFek9bU130_assertion evidence source_evidence_literature NP811801.RA1qMSpyuQJELTjXpZjD1iMo4cKMYR2sHIbv4yZFek9bU130_provenance.
- NP811801.RA1qMSpyuQJELTjXpZjD1iMo4cKMYR2sHIbv4yZFek9bU130_assertion SIO_000772 20463597 NP811801.RA1qMSpyuQJELTjXpZjD1iMo4cKMYR2sHIbv4yZFek9bU130_provenance.
- NP811801.RA1qMSpyuQJELTjXpZjD1iMo4cKMYR2sHIbv4yZFek9bU130_assertion wasDerivedFrom befree-2016 NP811801.RA1qMSpyuQJELTjXpZjD1iMo4cKMYR2sHIbv4yZFek9bU130_provenance.
- NP811801.RA1qMSpyuQJELTjXpZjD1iMo4cKMYR2sHIbv4yZFek9bU130_assertion wasGeneratedBy ECO_0000203 NP811801.RA1qMSpyuQJELTjXpZjD1iMo4cKMYR2sHIbv4yZFek9bU130_provenance.